Literature DB >> 33372982

Spectrum of Disease Severity in Patients With X-Linked Retinitis Pigmentosa Due to RPGR Mutations.

Valentina Di Iorio1, Marianthi Karali1,2, Paolo Melillo1, Francesco Testa1, Raffaella Brunetti-Pierri1, Francesco Musacchia2, Christel Condroyer3, John Neidhardt4,5, Isabelle Audo3,6,7, Christina Zeitz3, Sandro Banfi2,8, Francesca Simonelli1.   

Abstract

Purpose: The purpose of this study was to perform a detailed longitudinal phenotyping of X-linked retinitis pigmentosa (RP) caused by mutations in the RPGR gene during a long follow-up period.
Methods: An Italian cohort of 48 male patients (from 31 unrelated families) with RPGR-associated RP was clinically assessed at a single center (mean follow-up = 6.5 years), including measurements of best-corrected visual acuity (BCVA), Goldmann visual field (GVF), optical coherence tomography (OCT), fundus autofluorescence (FAF), microperimetry, and full-field electroretinography (ERG).
Results: Patients (29.6 ± 15.2 years) showed a mean BCVA of 0.6 ± 0.7 logMAR, mostly with myopic refraction (79.2%). Thirty patients (62.5%) presented a typical RP fundus, while the remaining sine pigmento RP. Over the follow-up, BCVA significantly declined at a mean rate of 0.025 logMAR/year. Typical RP and high myopia were associated with a significantly faster decline of BCVA. Blindness was driven primarily by GVF loss. ERG responses with a rod-cone pattern of dysfunction were detectable in patients (50%) that were significantly younger and more frequently presented sine pigmento RP. Thirteen patients (27.1%) had macular abnormalities without cystoid macular edema. Patients (50%) with a perimacular hyper-FAF ring were significantly younger, had a higher BCVA and a better-preserved ellipsoid zone band than those with markedly decreased FAF. Patients harboring pathogenic variants in exons 1 to 14 showed a milder phenotype compared to those with ORF15 mutations. Conclusions: Our monocentric, longitudinal retrospective study revealed a spectrum disease progression in male patients with RPGR-associated RP. Slow disease progression correlated with sine pigmento RP, absence of high myopia, and mutations in RPGR exons 1 to 14.

Entities:  

Year:  2020        PMID: 33372982      PMCID: PMC7774109          DOI: 10.1167/iovs.61.14.36

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  77 in total

1.  Clinical and immunohistochemical evidence for an X linked retinitis pigmentosa syndrome with recurrent infections and hearing loss in association with an RPGR mutation.

Authors:  A Iannaccone; D K Breuer; X F Wang; S F Kuo; E M Normando; E Filippova; A Baldi; S Hiriyanna; C B MacDonald; F Baldi; D Cosgrove; C C Morton; A Swaroop; M M Jablonski
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

2.  A presumed missense mutation of RPGR causes abnormal RNA splicing with exon skipping.

Authors:  F Yesim K Demirci; Amy L Radak; Brian W Rigatti; Tammy S Mah; Michael B Gorin
Journal:  Am J Ophthalmol       Date:  2004-09       Impact factor: 5.258

3.  The retinitis pigmentosa GTPase regulator (RPGR) interacts with novel transport-like proteins in the outer segments of rod photoreceptors.

Authors:  R Roepman; N Bernoud-Hubac; D E Schick; A Maugeri; W Berger; H H Ropers; F P Cremers; P A Ferreira
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

4.  The Spectrum of Structural and Functional Abnormalities in Female Carriers of Pathogenic Variants in the RPGR Gene.

Authors:  Mays Talib; Mary J van Schooneveld; Caroline Van Cauwenbergh; Jan Wijnholds; Jacoline B Ten Brink; Ralph J Florijn; Nicoline E Schalij-Delfos; Gislin Dagnelie; Maria M van Genderen; Elfride De Baere; Magda A Meester-Smoor; Julie De Zaeytijd; Frans P M Cremers; L Ingeborgh van den Born; Alberta A Thiadens; Carel B Hoyng; Caroline C Klaver; Bart P Leroy; Arthur A Bergen; Camiel J F Boon
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

5.  VarGenius executes cohort-level DNA-seq variant calling and annotation and allows to manage the resulting data through a PostgreSQL database.

Authors:  F Musacchia; A Ciolfi; M Mutarelli; A Bruselles; R Castello; M Pinelli; S Basu; S Banfi; G Casari; M Tartaglia; V Nigro
Journal:  BMC Bioinformatics       Date:  2018-12-12       Impact factor: 3.169

6.  X-linked Retinitis Pigmentosa in Japan: Clinical and Genetic Findings in Male Patients and Female Carriers.

Authors:  Kentaro Kurata; Katsuhiro Hosono; Takaaki Hayashi; Kei Mizobuchi; Satoshi Katagiri; Daisuke Miyamichi; Sachiko Nishina; Miho Sato; Noriyuki Azuma; Tadashi Nakano; Yoshihiro Hotta
Journal:  Int J Mol Sci       Date:  2019-03-26       Impact factor: 5.923

7.  Clinical and genetic characteristics of 14 patients from 13 Japanese families with RPGR-associated retinal disorder: report of eight novel variants.

Authors:  Go Mawatari; Kaoru Fujinami; Xiao Liu; Lizhu Yang; Yu-Fujinami Yokokawa; Shiori Komori; Shinji Ueno; Hiroko Terasaki; Satoshi Katagiri; Takaaki Hayashi; Kazuki Kuniyoshi; Yozo Miyake; Kazushige Tsunoda; Kazutoshi Yoshitake; Takeshi Iwata; Nobuhisa Nao-I
Journal:  Hum Genome Var       Date:  2019-08-02

8.  A Comparison of Methods for Tracking Progression in X-Linked Retinitis Pigmentosa Using Frequency Domain OCT.

Authors:  Rithambara Ramachandran; Lisa Zhou; Kirsten G Locke; David G Birch; Donald C Hood
Journal:  Transl Vis Sci Technol       Date:  2013-11-11       Impact factor: 3.283

9.  Expanding the phenotype of PRPS1 syndromes in females: neuropathy, hearing loss and retinopathy.

Authors:  Berta Almoguera; Sijie He; Marta Corton; Patricia Fernandez-San Jose; Fiona Blanco-Kelly; Maria Isabel López-Molina; Blanca García-Sandoval; Javier Del Val; Yiran Guo; Lifeng Tian; Xuanzhu Liu; Liping Guan; Rosa J Torres; Juan G Puig; Hakon Hakonarson; Xun Xu; Brendan Keating; Carmen Ayuso
Journal:  Orphanet J Rare Dis       Date:  2014-12-10       Impact factor: 4.123

10.  Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR.

Authors:  Jasmina Cehajic-Kapetanovic; Kanmin Xue; Cristina Martinez-Fernandez de la Camara; Anika Nanda; Alexandra Davies; Laura J Wood; Anna Paola Salvetti; M Dominik Fischer; James W Aylward; Alun R Barnard; Jasleen K Jolly; Edmond Luo; Brandon J Lujan; Tuyen Ong; Aniz Girach; Graeme C M Black; Ninel Z Gregori; Janet L Davis; Potyra R Rosa; Andrew J Lotery; Byron L Lam; Paulo E Stanga; Robert E MacLaren
Journal:  Nat Med       Date:  2020-02-24       Impact factor: 53.440

View more
  3 in total

1.  Clinical and Molecular Characterization of Achromatopsia Patients: A Longitudinal Study.

Authors:  Raffaella Brunetti-Pierri; Marianthi Karali; Paolo Melillo; Valentina Di Iorio; Antonella De Benedictis; Gennarfrancesco Iaccarino; Francesco Testa; Sandro Banfi; Francesca Simonelli
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

Review 2.  Genetic dissection of non-syndromic retinitis pigmentosa.

Authors:  Aarti Bhardwaj; Anshu Yadav; Manoj Yadav; Mukesh Tanwar
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

3.  Novel TTLL5 Variants Associated with Cone-Rod Dystrophy and Early-Onset Severe Retinal Dystrophy.

Authors:  Vasily Smirnov; Olivier Grunewald; Jean Muller; Christina Zeitz; Carolin D Obermaier; Aurore Devos; Valérie Pelletier; Béatrice Bocquet; Camille Andrieu; Jean-Louis Bacquet; Elodie Lebredonchel; Saddek Mohand-Saïd; Sabine Defoort-Dhellemmes; José-Alain Sahel; Hélène Dollfus; Xavier Zanlonghi; Isabelle Audo; Isabelle Meunier; Elise Boulanger-Scemama; Claire-Marie Dhaenens
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.